marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Xtant Medical Holdings Balance Sheet 2011-2025 | XTNT
Annual Balance Sheet Xtant Medical Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
12.3 M | -10.2 M | -5.99 M | 31.3 M | 73.3 M | 71.8 M | 136 M | 127 M | 106 M | 16.5 M | 13.4 M | 9.6 M | 7.52 M |
Long Term Debt |
17.2 M | 9.69 M | 11.8 M | 16.8 M | 76.2 M | 77.9 M | 138 M | 119 M | 113 M | 20.9 M | 16.4 M | 14.5 M | 6.64 M |
Long Term Debt Current |
830 K | 458 K | 462 K | 423 K | 394 K | - | - | - | - | 50.7 K | 47.7 K | 45.1 K | 1.63 M |
Total Non Current Liabilities |
- | - | - | 16.8 M | 78 M | 78.1 M | 139 M | 120 M | 113 M | 27.2 M | 23.1 M | 21.6 M | 6.73 M |
Total Current Liabilities |
23 M | 15.2 M | 11.1 M | 25.6 M | 9.39 M | 12.1 M | 25.8 M | 31.1 M | 21.5 M | 8.48 M | 9.65 M | 8.69 M | 10.9 M |
Total Liabilities |
41.3 M | 26.1 M | 23.8 M | 27 M | 87.4 M | 90.2 M | 164 M | 151 M | 134 M | 35.7 M | 32.7 M | 30.3 M | 17.7 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-243 M | -244 M | -235 M | - | -223 M | -215 M | -145 M | -92.5 M | -73 M | -70.9 M | -60.4 M | -47.7 M | -40 M |
Total Assets |
92.6 M | 60.2 M | 54.7 M | 41.5 M | 43.2 M | 46.4 M | 106 M | 144 M | 143 M | 28 M | 28.9 M | 34.5 M | 23.2 M |
Cash and Cash Equivalents |
5.72 M | 20.3 M | 18.2 M | 2.34 M | 5.24 M | 6.8 M | 2.86 M | 2.58 M | 6.37 M | 4.47 M | 3.05 M | 4.93 M | 751 K |
Book Value |
51.3 M | 34.2 M | 30.9 M | 14.5 M | -44.2 M | -43.8 M | -58.7 M | -7.07 M | 8.88 M | -7.77 M | -3.84 M | 4.23 M | 5.5 M |
Total Shareholders Equity |
51.3 M | 34.2 M | 30.9 M | 14.5 M | -44.2 M | -43.8 M | -58.7 M | -7.07 M | 8.88 M | -7.77 M | -3.84 M | 4.23 M | 5.5 M |
All numbers in USD currency
Quarterly Balance Sheet Xtant Medical Holdings
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
19.1 M | 21.8 M | 16.8 M | 17.2 M | 14.4 M | 16.4 M | 12.3 M | 9.69 M | 10.6 M | - | 11.8 M | 11.8 M | 11.7 M | 11.7 M | 129 K | 1.3 M | 79.6 M | 77.5 M | 77.3 M | 76.2 M | 76.2 M | 76.2 M | 76.2 M | 77.9 M | 77.9 M | 77.9 M | 77.9 M | 67.1 M | 67.1 M | 67.1 M | 138 M | 119 M | 49.5 M | 46.7 M | 45.9 M | 44.2 M | 44.3 M | 44.2 M | 44.2 M | 20.9 M | 20.9 M | 20.9 M | 20.9 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 6.64 M | 6.64 M | 6.64 M | 6.64 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
53.2 M | 50.6 M | 46.3 M | 41.3 M | 37.3 M | 34.3 M | 30.6 M | 26.1 M | 23.3 M | - | 23.9 M | 23.8 M | 23.2 M | 25.8 M | 25.3 M | 27 M | 27 M | 27 M | 27 M | 87.4 M | 87.4 M | 87.4 M | 87.4 M | 90.2 M | 90.2 M | 90.2 M | 90.2 M | 164 M | 164 M | 164 M | 164 M | 151 M | 151 M | 151 M | 151 M | 132 M | 132 M | 132 M | 132 M | 35.7 M | 35.7 M | 35.7 M | 35.7 M | 32.7 M | 32.7 M | 32.7 M | 32.7 M | 30.3 M | 30.3 M | 30.3 M | 30.3 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-256 M | -251 M | -247 M | -243 M | -239 M | -248 M | -246 M | -244 M | -241 M | - | -237 M | -235 M | -233 M | -231 M | -230 M | -230 M | -230 M | -230 M | -230 M | -223 M | -223 M | -223 M | -223 M | -215 M | -215 M | -215 M | -215 M | -145 M | -145 M | -145 M | -145 M | -92.5 M | -92.5 M | -92.5 M | -92.5 M | -73 M | -73 M | -73 M | -73 M | -70.9 M | -70.9 M | -70.9 M | -70.9 M | -60.4 M | -60.4 M | -60.4 M | -60.4 M | -47.7 M | -47.7 M | -47.7 M | -47.7 M | -40 M | -40 M | -40 M | -40 M |
Total Assets |
98.9 M | 95.6 M | 93.9 M | 92.6 M | 92 M | 65.2 M | 63.3 M | 60.2 M | 56 M | - | 53.2 M | 54.7 M | 55.8 M | 59.7 M | 58.7 M | 41.5 M | 41.5 M | 41.5 M | 41.5 M | 43.2 M | 43.2 M | 43.2 M | 43.2 M | 46.4 M | 46.4 M | 46.4 M | 46.4 M | 106 M | 106 M | 106 M | 106 M | 144 M | 144 M | 144 M | 144 M | 141 M | 141 M | 141 M | 141 M | 28 M | 28 M | 28 M | 28 M | 28.9 M | 28.9 M | 28.9 M | 28.9 M | 34.5 M | 34.5 M | 34.5 M | 34.5 M | 23.2 M | 23.2 M | 23.2 M | 23.2 M |
Cash and Cash Equivalents |
6.6 M | 5.38 M | 4.55 M | 5.72 M | 8.66 M | 4.14 M | 5.18 M | 20.3 M | 17.4 M | 16.5 M | 16.8 M | 18.2 M | 18.2 M | 20.3 M | 18.6 M | 2.34 M | 2.34 M | 2.34 M | 2.34 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 2.86 M | 2.86 M | 2.86 M | 2.86 M | 2.58 M | 2.58 M | 2.58 M | 2.58 M | 6.37 M | 6.37 M | 6.37 M | 6.37 M | 4.47 M | 4.47 M | 4.47 M | 4.47 M | 3.05 M | 3.05 M | 3.05 M | 3.05 M | 4.93 M | 4.93 M | 4.93 M | 4.93 M | 751 K | 751 K | 751 K | 751 K |
Book Value |
45.7 M | 45 M | 47.7 M | 51.3 M | 54.7 M | 31 M | 32.7 M | 34.2 M | 32.8 M | - | 29.3 M | 30.9 M | 32.6 M | 33.9 M | 33.4 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | -44.2 M | -44.2 M | -44.2 M | -44.2 M | -43.8 M | -43.8 M | -43.8 M | -43.8 M | -58.7 M | -58.7 M | -58.7 M | -58.7 M | -7.07 M | -7.07 M | -7.07 M | -7.07 M | 8.88 M | 8.88 M | 8.88 M | 8.88 M | -7.77 M | -7.77 M | -7.77 M | -7.77 M | -3.84 M | -3.84 M | -3.84 M | -3.84 M | 4.23 M | 4.23 M | 4.23 M | 4.23 M | 5.5 M | 5.5 M | 5.5 M | 5.5 M |
Total Shareholders Equity |
45.7 M | 45 M | 47.7 M | 51.3 M | 54.7 M | 31 M | 32.7 M | 34.2 M | 32.8 M | 28.1 M | 29.3 M | 30.9 M | 32.6 M | 33.9 M | 33.4 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | -44.2 M | -44.2 M | -44.2 M | -44.2 M | -43.8 M | -43.8 M | -43.8 M | -43.8 M | -58.7 M | -58.7 M | -58.7 M | -58.7 M | -7.07 M | -7.07 M | -7.07 M | -7.07 M | 8.88 M | 8.88 M | 8.88 M | 8.88 M | -7.77 M | -7.77 M | -7.77 M | -7.77 M | -3.84 M | -3.84 M | -3.84 M | -3.84 M | 4.23 M | 4.23 M | 4.23 M | 4.23 M | 5.5 M | 5.5 M | 5.5 M | 5.5 M |
All numbers in USD currency